$50.49
-$0.13
(-0.26%)
Gilead Sciences
NASDAQ:GILD
Related Resources
GILD
vs. S&P 500
|
$50.49
-$0.13
(-0.26%)
|
|
| Today's Open | $50.74 |
|---|---|
| Previous Close | $50.62 |
| Daily Range | $50.18 - $50.76 |
| 52-Week Range | $34.45 - $56.50 |
| Market Cap | $38.2B |
| P/E Ratio | 15.25 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,882,525 |
| Average Daily Volume | 7,653,562 |
| Current FY EPS | $3.43 |
Sector
Healthcare
Industry
Biotechnology
Description
Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.
News & Commentary
The Meaningless Drug Approval That Could Cost the Industry Billions
Latest from DailyFinance
